EP0209192A1 - Liquide pour lentille de contact - Google Patents

Liquide pour lentille de contact Download PDF

Info

Publication number
EP0209192A1
EP0209192A1 EP86201215A EP86201215A EP0209192A1 EP 0209192 A1 EP0209192 A1 EP 0209192A1 EP 86201215 A EP86201215 A EP 86201215A EP 86201215 A EP86201215 A EP 86201215A EP 0209192 A1 EP0209192 A1 EP 0209192A1
Authority
EP
European Patent Office
Prior art keywords
contact
weight
carbon atoms
lens liquid
liquid according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP86201215A
Other languages
German (de)
English (en)
Other versions
EP0209192B1 (fr
Inventor
Hans Van Doorne
Adrianus Franciscus Spruijt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Pharmaceuticals Holland BV
Bausch Health Americas Inc
Original Assignee
ICN Pharmaceuticals Holland BV
ICN Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ICN Pharmaceuticals Holland BV, ICN Pharmaceuticals Inc filed Critical ICN Pharmaceuticals Holland BV
Priority to AT86201215T priority Critical patent/ATE64100T1/de
Publication of EP0209192A1 publication Critical patent/EP0209192A1/fr
Application granted granted Critical
Publication of EP0209192B1 publication Critical patent/EP0209192B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12

Definitions

  • the invention relates to a contact-lens liquid which contains
  • Such contact-lens liquids are generally known.
  • US Patent 4,048,122 also describes a cleaning liquid for soft and silicone contact-lenses in which use is made of the same fatty acid as described above, toge­ther with a water-soluble polyalkyleneoxy-modified di­methylsilicone resin.
  • Contact-lens liquids are solutions which are in­tended to make a prolonged and comfortable use of lenses possible. Because the liquid may come/comes into direct contact with one of the most sensitive organs of the hu­man body (the eye), they have to be sterile products. Two alternatives may be considered for guaranteeing the sterility during use. Firstly, the solutions may be sup­plied in so-called single-dose units. However, this is an expensive option. Secondly, a suitable compound with antimicrobial activity may be added to the product. The vast majority of manufacturers of contact-lens liquids have chosen this solution.
  • the manufacturer is subject to certain limita­tions with regard to the choice of the preservative to be used.
  • the finished contact-lens liquid must meet cer­tain minimum requirements with regard to the antimicro­bial action.
  • the following requirements may be imposed for a so-called all-in-one liquid, i.e. a product which is intended for disinfecting, cleaning, preserving and inserting the lenses: - for bacteria, a reduction of the number of live nuclei by at least a factor of 1000 must be achieved in a period of six hours. In the specialist literature this is often expressed in two other ways, viz. reduc­tion by at least three powers of ten or a reduction by three logarithmic cycles must be achieved. - for yeasts and moulds a reduction of at least a factor of 100 (a reduction by two powers of ten or two loga­rithmic cycles) must be achieved within a period of two weeks.
  • R represents an alkyl radical having 5-17 carbon atoms.
  • the compounds having the formulae 1 to 3 are al­ready known and in particular, from the US Patent 4,209,449, in which it is reported that they have excel­lent foaming, viscosity-enhancing, wetting, cleansing, detergent, antistatic-promoting, emulsifying and bacterio­15static properties. These very stable compounds are tole­rated well by human tissue and exhibit a low oral toxic­ity and low eye irritation. It is indicated that as a result they are outstandingly suitable for use for cosmetic purposes as well as for use in industry.
  • the composition contains component a) in a concentration of at most 10% by weight, preferively at most 5% by weight.
  • a suitable component a) is dipluronic (poloxamer). This is preferably used in a quantity of at most 1.0% by weight of dipluronic, very particularly 0.2 - 0.6% by weight of dipluronic.
  • the sodium chloride is expediently present in a concentration of at most 2% by weight.
  • As a buffering substance pre­ferably at most 17% by weight of borax (disodium borate) together with at most 10% by weight of boric acid, is used.
  • borax diisodium borate
  • EDTA preferably disodium EDTA is used in a concentration of at most 3% by weight. A content of 0.5% by weight of disodium EDTA is preferred.
  • the content of sodium chloride is preferably at most 0.5% by weight, while the content of boric acid is preferably 0.5-2.5% by weight.
  • the content of sodium borate is preferably 0.05-5% by weight, in particular 0.01-0.8% by weight.

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Detergent Compositions (AREA)
  • Eyeglasses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP86201215A 1985-07-11 1986-07-11 Liquide pour lentille de contact Expired - Lifetime EP0209192B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AT86201215T ATE64100T1 (de) 1985-07-11 1986-07-11 Kontaktlinsenfluessigkeit.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8502002A NL8502002A (nl) 1985-07-11 1985-07-11 Contactlensvloeistof.
NL8502002 1985-07-11

Publications (2)

Publication Number Publication Date
EP0209192A1 true EP0209192A1 (fr) 1987-01-21
EP0209192B1 EP0209192B1 (fr) 1991-06-05

Family

ID=19846287

Family Applications (1)

Application Number Title Priority Date Filing Date
EP86201215A Expired - Lifetime EP0209192B1 (fr) 1985-07-11 1986-07-11 Liquide pour lentille de contact

Country Status (4)

Country Link
EP (1) EP0209192B1 (fr)
AT (1) ATE64100T1 (fr)
DE (1) DE3679605D1 (fr)
NL (1) NL8502002A (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427548A3 (en) * 1989-11-09 1991-07-17 Polymer Technology Corporation Contact lens cleaning material and method
EP0381618A3 (fr) * 1989-01-31 1992-02-26 Ciba-Geigy Ag Composition désinfectante et nettoyante pour lentilles de contact
EP0381617A3 (fr) * 1989-01-31 1992-03-04 Ciba-Geigy Ag Composition désinfectante et nettoyante pour lentilles de contact
US5298182A (en) * 1989-01-31 1994-03-29 Ciba-Geigy Corporation Rapid ophthalmic glycol/lower alkanol cleaning and disinfecting solution and method
WO1995001414A1 (fr) * 1993-07-01 1995-01-12 Allergan, Inc. Solution de nettoyage de lentilles de contact a base d'esters phosphates d'ammonium quaternaire

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1921358A1 (de) * 1968-04-26 1969-11-06 Flow Pharma Inc Waessrige Fluessigkeit zum Reinigen und keimfreien Lagern von Gegenstaenden
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US4209449A (en) * 1978-11-30 1980-06-24 Mona Industries Phosphate quaternary compounds
EP0095524A1 (fr) * 1982-06-01 1983-12-07 Hoya Lens Corporation Composition pour la conservation de lentilles de contact souples

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1921358A1 (de) * 1968-04-26 1969-11-06 Flow Pharma Inc Waessrige Fluessigkeit zum Reinigen und keimfreien Lagern von Gegenstaenden
FR2195802A1 (fr) * 1968-04-26 1974-03-08 Flow Pharma Inc
US4029817A (en) * 1973-09-24 1977-06-14 Allergan Pharmaceuticals Soft contact lens preserving solutions
US4209449A (en) * 1978-11-30 1980-06-24 Mona Industries Phosphate quaternary compounds
EP0095524A1 (fr) * 1982-06-01 1983-12-07 Hoya Lens Corporation Composition pour la conservation de lentilles de contact souples

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0381618A3 (fr) * 1989-01-31 1992-02-26 Ciba-Geigy Ag Composition désinfectante et nettoyante pour lentilles de contact
EP0381617A3 (fr) * 1989-01-31 1992-03-04 Ciba-Geigy Ag Composition désinfectante et nettoyante pour lentilles de contact
US5298182A (en) * 1989-01-31 1994-03-29 Ciba-Geigy Corporation Rapid ophthalmic glycol/lower alkanol cleaning and disinfecting solution and method
US5411598A (en) * 1989-01-31 1995-05-02 Ciba-Geigy Corporation Rapid method for cleaning/disinfecting ophthalmic devices using novel glycol/lower alkanol solution
EP0427548A3 (en) * 1989-11-09 1991-07-17 Polymer Technology Corporation Contact lens cleaning material and method
US5190594A (en) * 1989-11-09 1993-03-02 Polymer Technology Corporation Contact lens cleaning material and method
WO1995001414A1 (fr) * 1993-07-01 1995-01-12 Allergan, Inc. Solution de nettoyage de lentilles de contact a base d'esters phosphates d'ammonium quaternaire

Also Published As

Publication number Publication date
ATE64100T1 (de) 1991-06-15
EP0209192B1 (fr) 1991-06-05
DE3679605D1 (de) 1991-07-11
NL8502002A (nl) 1987-02-02

Similar Documents

Publication Publication Date Title
US4209449A (en) Phosphate quaternary compounds
JPS60109511A (ja) クレンジング用化粧料組成物
ES8507541A1 (es) Un procedimiento para la preparacion de 1h-imidazolez y 1h-1,2,4-triazoles.
US4456543A (en) Bisbiguanide based antibacterial cleansing products
MY104597A (en) Herbicidal agents.
JPS6185301A (ja) コンタクトレンズの消毒保存用溶液
US4278654A (en) Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer
US4252826A (en) Cosmetic composition for removing makeup from the eyes
US4503002A (en) Phosphate quaternary compounds
BR8902086A (pt) Processo para preparacao de monopersulfatos de acido(poli)peroxicarboxilico derivados de amino
EP0209192A1 (fr) Liquide pour lentille de contact
DK27084A (da) Kompositioner aktive mod mider, mellus og thrips, farmaceutisk komposition og benzoylurinstof-forbindelser
US4336385A (en) Phosphate imidazolinium compounds
JPH0460571B2 (fr)
JPS60161498A (ja) 洗浄剤組成物
RU97111817A (ru) Новые гербицидные композиции
JPH01104003A (ja) 殺菌性組成物
DE59207471D1 (de) Zubereitungen zur haarbehandlung
JPS56169617A (en) Hair cosmetic
PT89244A (pt) Processo de preparacao de derivados de tioformamida terapeuticamente activos e de seus intermediarios
JPS5756412A (en) Hair cosmetic
PT77147A (en) Process for the preparation of a fungicidal composition containing azolyl-phenoxy-tetrahydrofuran-2-ylidene-methanes
IL86136A (en) Thiadiazole guanidines,process for preparation thereof and pharmaceutical compositions containing the same
DE3373777D1 (en) Improvements in or relating to quaternary ammonium compound disinfectants for use in bovine mastitis control
ATE37541T1 (de) Substituierte hydroxyalkyl-azole, verfahren zu ihrer herstellung sowie diese enthaltende antimykotische mittel.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19870501

17Q First examination report despatched

Effective date: 19880616

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

REF Corresponds to:

Ref document number: 64100

Country of ref document: AT

Date of ref document: 19910615

Kind code of ref document: T

ET Fr: translation filed
ITF It: translation for a ep patent filed
REF Corresponds to:

Ref document number: 3679605

Country of ref document: DE

Date of ref document: 19910711

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
EPTA Lu: last paid annual fee
EAL Se: european patent in force in sweden

Ref document number: 86201215.0

REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20030709

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: LU

Payment date: 20030711

Year of fee payment: 18

Ref country code: FR

Payment date: 20030711

Year of fee payment: 18

Ref country code: AT

Payment date: 20030711

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040711

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040711

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20040711

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20040711

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050331

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20050531

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20050706

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20050707

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20050711

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20050713

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20050913

Year of fee payment: 20

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20060711

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

NLV7 Nl: ceased due to reaching the maximum lifetime of a patent

Effective date: 20060711

EUG Se: european patent has lapsed
BE20 Be: patent expired

Owner name: *ICN PHARMACEUTICALS HOLLAND B.V.

Effective date: 20060711